Introduce Lurbinectedin in Central Vein, Perc, New Tech 7

This code describes the administration of Lurbinectedin, an antineoplastic agent, directly into a central vein. The procedure is performed percutaneously, meaning through the skin, typically using a catheter inserted into a large vein such as the subclavian, jugular, or femoral vein. This method ensures rapid and systemic distribution of the drug.

This code is used when Lurbinectedin is administered intravenously via a central venous access device. This typically occurs in the treatment of metastatic small cell lung cancer (SCLC) or other malignancies where Lurbinectedin is indicated. It specifically applies to the initial or subsequent infusions of this particular drug.

• Ensure documentation clearly specifies "Lurbinectedin" as the substance introduced.
• Verify the approach is documented as "percutaneous" and the site is a "central vein."
• This code is specific to New Technology Group 7, indicating a novel therapeutic agent.